<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03960749</url>
  </required_header>
  <id_info>
    <org_study_id>HELP Umeå</org_study_id>
    <nct_id>NCT03960749</nct_id>
  </id_info>
  <brief_title>Headache After Diagnostic Lumbar Puncture</brief_title>
  <acronym>HELPUmeå</acronym>
  <official_title>The Importance of Needle Size, Needle Design and Stylet Reinsertion to Prevent Post-lumbar Puncture Headache, a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jonatan Salzer</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Umeå University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Västerbotten County Council</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of this study are to investigate the effects of needle design, needle size and
      stylet reinsertion on the risk for headache after diagnostic LP (lumbar puncture, Post-LP
      headache). The following needles are used in the study:

        1. Sprotte 25 Gauge (G) (0.5 mm) atraumatic needle with introducer

        2. Sprotte 22 G (0.7 mm) atraumatic needle with introducer

        3. Spinocan 25 G (0.5 mm) cutting needle
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 28, 2013</start_date>
  <completion_date type="Actual">October 11, 2018</completion_date>
  <primary_completion_date type="Actual">June 24, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized, parallel group. Randomization between three different lumbar puncture needles and between stylet reinsertion of not before needle withdrawal.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>The participants are not informed about the allocated needle. The follow-up telephone calls (outcome assessment) are made by an assistant nurse who is unaware of randomization allocation.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Odds ratio for post-lumbar puncture headache (any)</measure>
    <time_frame>Up to 14 days after LP</time_frame>
    <description>Any post-lumbar puncture headache (as defined in the international classification of headache disorders 3 (ICHD-3).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Odds ratio for post-lumbar puncture headache (severe)</measure>
    <time_frame>Up to 14 days after LP</time_frame>
    <description>Severe (preventing daily activities) post-lumbar puncture headache (as defined in the international classification of headache disorders 3 (ICHD-3).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Headache duration (days)</measure>
    <time_frame>Until cessation, up to 14 days after LP</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion using analgesia</measure>
    <time_frame>During post-lumbar puncture headache, up to 14 days after LP</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion on sick leave</measure>
    <time_frame>During post-lumbar puncture headache, up to 14 days after LP</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion with back pain</measure>
    <time_frame>Up to 14 days after LP</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion with radiating leg pain</measure>
    <time_frame>Up to 14 days after LP</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Multiplicative interactions between age (years), sex, BMI and needle visavi the outcome &quot;any post-LP headache&quot; in a multivariable logistic regression model</measure>
    <time_frame>Up to 14 days after LP</time_frame>
    <description>Interactions between important predictors of headache and needle allocation, assessed in multivariable logistic regression models with interaction terms which are the products of the two potentially interacting variables. Age and BMI will be treated as continuous variables, sex and needle allocation as categorical variables.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Procedure duration (minutes)</measure>
    <time_frame>During the lumbar puncture</time_frame>
    <description>Procedure duration from start of procedure (defined as when the operator starts palpating the iliac crest) until procedure cessation (defined as when the needle is withdrawn from the participant).</description>
  </other_outcome>
  <other_outcome>
    <measure>Proportion undergoing needle switch</measure>
    <time_frame>During the lumbar puncture</time_frame>
    <description>Technical difficulties may differ between needles and thus the proportion undergoing needle switch due to these difficulties may differ.</description>
  </other_outcome>
  <other_outcome>
    <measure>Opening pressure (cm H2O)</measure>
    <time_frame>During the lumbar puncture</time_frame>
    <description>Opening pressure measured immediately after cerebrospinal fluid (CSF) contact using a thin tube attached to a paper ruler, using the skin entry hole as reference point. This is only performed in the recumbent position.</description>
  </other_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">1000</enrollment>
  <condition>Post-Lumbar Puncture Headache</condition>
  <arm_group>
    <arm_group_label>Sprotte 25G needle, stylet reinserted</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sprotte 25G needle, stylet not reinserted</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sprotte 22G needle, stylet reinserted</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sprotte 22G needle, stylet not reinserted</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Spinocan 25G needle, stylet reinserted</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Spinocan 25G needle, stylet not reinserted</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sprotte 25G needle, stylet reinserted</intervention_name>
    <description>Lumbar puncture with small bore atraumatic needle, stylet reinserted before needle withdrawal</description>
    <arm_group_label>Sprotte 25G needle, stylet reinserted</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sprotte 25G needle, stylet not reinserted</intervention_name>
    <description>Lumbar puncture with small bore atraumatic needle, stylet not reinserted before needle withdrawal</description>
    <arm_group_label>Sprotte 25G needle, stylet not reinserted</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sprotte 22G needle, stylet reinserted</intervention_name>
    <description>Lumbar puncture with larger bore atraumatic needle, stylet reinserted before needle withdrawal</description>
    <arm_group_label>Sprotte 22G needle, stylet reinserted</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sprotte 22G needle, stylet not reinserted</intervention_name>
    <description>Lumbar puncture with larger bore atraumatic needle, stylet not reinserted before needle withdrawal</description>
    <arm_group_label>Sprotte 22G needle, stylet not reinserted</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Spinocan 25G needle, stylet reinserted</intervention_name>
    <description>Lumbar puncture with small bore cutting needle, stylet reinserted before needle withdrawal</description>
    <arm_group_label>Spinocan 25G needle, stylet reinserted</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Spinocan 25G needle, stylet not reinserted</intervention_name>
    <description>Lumbar puncture with small bore cutting needle, stylet not reinserted before needle withdrawal</description>
    <arm_group_label>Spinocan 25G needle, stylet not reinserted</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects undergoing diagnostic LP during their neurological work-up at Umeå University
             Hospital, Sweden, from 28 May 2013 until the study is fully recruited and;

          -  Willing to participate and

          -  Providing informed consent

        Exclusion Criteria:

        -Subjects unable to participate in the study follow-up
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>Evans RW, Armon C, Frohman EM, Goodin DS. Assessment: prevention of post-lumbar puncture headaches: report of the therapeutics and technology assessment subcommittee of the american academy of neurology. Neurology. 2000 Oct 10;55(7):909-14.</citation>
    <PMID>11061243</PMID>
  </reference>
  <reference>
    <citation>Hyllienmark L, Zachau AC. [Diagnostic lumbal puncture]. Lakartidningen. 2008 Oct 8-14;105(41):2844-9. Swedish.</citation>
    <PMID>19009898</PMID>
  </reference>
  <reference>
    <citation>Armon C, Evans RW; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Addendum to assessment: Prevention of post-lumbar puncture headaches: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2005 Aug 23;65(4):510-2.</citation>
    <PMID>16116106</PMID>
  </reference>
  <reference>
    <citation>Strupp M, Brandt T. Should one reinsert the stylet during lumbar puncture? N Engl J Med. 1997 Apr 17;336(16):1190.</citation>
    <PMID>9102578</PMID>
  </reference>
  <reference>
    <citation>Hammond ER, Wang Z, Bhulani N, McArthur JC, Levy M. Needle type and the risk of post-lumbar puncture headache in the outpatient neurology clinic. J Neurol Sci. 2011 Jul 15;306(1-2):24-8. doi: 10.1016/j.jns.2011.04.004. Epub 2011 May 5.</citation>
    <PMID>21549395</PMID>
  </reference>
  <reference>
    <citation>Strupp M, Schueler O, Straube A, Von Stuckrad-Barre S, Brandt T. &quot;Atraumatic&quot; Sprotte needle reduces the incidence of post-lumbar puncture headaches. Neurology. 2001 Dec 26;57(12):2310-2.</citation>
    <PMID>11756618</PMID>
  </reference>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 2, 2019</study_first_submitted>
  <study_first_submitted_qc>May 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 23, 2019</study_first_posted>
  <last_update_submitted>May 20, 2019</last_update_submitted>
  <last_update_submitted_qc>May 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Västerbotten County Council</investigator_affiliation>
    <investigator_full_name>Jonatan Salzer</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Lumbar puncture</keyword>
  <keyword>Headache</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Post-Dural Puncture Headache</mesh_term>
    <mesh_term>Headache</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 17, 2014</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/49/NCT03960749/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

